Brief: Theradiag, Quotient Ltd Partner On Autoimmune Disease Diagnostics

Theradiag SA

08/06/2022 10:10

June 8 (Reuters) - Theradiag SA  ALTHE.PA :
    * QUOTIENT LIMITED AND THERADIAG ANNOUNCE PARTNERSHIP TO
ADVANCE
AUTOIMMUNE DISEASE DIAGNOSTICS
    * EXPANDS ACCESS TO $2 BILLION AUTOIMMUNE IVD SPECIALTY
MARKET
WITH MOSAIQ
    * TARGETED MARKET INTRODUCTION IN LATER HALF OF CY2023
    * UNDER NEW AGREEMENT, THERADIAG WILL SUPPLY QUOTIENT WITH
AUTOIMMUNE REAGENTS AND MULTI-CONSTITUENT QUALITY CONTROLS, FOR
DEVELOPMENT OF AUTOIMMUNE MICROARRAYS TO BE USED ON MOSAIQ
SOLUTION
    * PARTIES INTEND FIRST APPLICATION COVERED BY THEIR NEW
COLLABORATION WILL BE A SOLUTION FOR CONNECTIVE TISSUE DISEASES
(CTD)

Source text for Eikon:  ID:nBw96FHjQa 
Further company coverage:  ALTHE.PA   QTNT.O 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 587 696 600;))